J-DOIT3: ‘Aim for Near-Normal Metabolic Parameters’ in Diabetes

UPDATED // The large Japanese DOIT3 trial tells clinicians that optimal lipid, blood pressure, and, glycemic control are important to reduce microvascular and macrovascular complications in type 2 diabetes.
Medscape Medical News

Full Story →